Insulet Hit With Derivative Suit Over Lack Of Disclosure
Executives at Insulet Corp., a manufacturer of insulin pumps, misrepresented the success of a new-product rollout, ultimately causing shares of the company to plunge, a shareholder claimed in a derivative suit...To view the full article, register now.
Already a subscriber? Click here to view full article